|
[1]
|
Ishida, Y., Agata, Y., Shibahara, K. and Honjo, T. (1992) Induced Expression of PD-1, a Novel Member of the Immunoglobulin Gene Superfamily, upon Programmed Cell Death. EMBO Journal, 11, 3887-3895.
|
|
[2]
|
Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T. (1999) Development of Lupus-Like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor. Immunity, 11, 141-151. [Google Scholar] [CrossRef]
|
|
[3]
|
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., et al. (2001) Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice. Science, 291, 319-322. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Dong, H., Zhu, G., Tamada, K. and Chen, L. (1999) B7-H1, a Third Member of the B7 Family, Costimulates T-Cell Proliferation and Interleukin-10 Secretion. Nature Medicine, 5, 1365-1369. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Freeman, G.J., Long, A.J., Iwai, Y., Bourque, K., Chernova, T., et al. (2000) Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation. Journal of Experimental Medicine, 192, 1027-1034. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Latchman, Y., Wood, C.R., Chernova, T., Chaudhary, D., Borde, M., et al. (2001) PD-L2 Is a Second Ligand for PD-1 and Inhibits T Cell Activation. Nature Immunology, 2, 261-268. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Tseng, S.Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J.E., et al. (2001) B7-DC, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells. Journal of Experimental Medicine, 193, 839-846. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Keir, M.E., et al. (2008) PD-1 and Its Ligands in Tolerance and Immunity. Annual Review of Immunology, 26, 677-704. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Böger, C., Behrens, H.M., Mathiak, M., et al. (2016) PD-L1 Is an Independent Prognostic Predictor in Gastric Cancer of Western Patients. Oncotarget, 7, 24269-24283. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Iraolagoitia, X.L., Spallanzani, R.G., Torres, N.I., et al. (2016) NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells. Journal of Immunology, 197, 953-961. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Leng, C., Li, Y., Qin, J., et al. (2016) Relationship between Expression of PDL1 and PD-L2 on Esophageal Squamous Cell Carcinoma and the Antitumor Effects of CD8+ T Cells. Oncology Report, 35, 699-708. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Hughes, P.E., Caenepeel, S., Wu, L.C., et al. (2016) Targeted Therapyand Checkpoint Immunotherapy Combinations for the Treatment of Cancer. Trends in Immunology, 37, 462-476. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
谢丽叶, 付杰军, 卢奕, 张健. PD1/PD-L1激活促进癌症发生、发展和转移的研究进展[J]. 肿瘤防治研究, 2017, 44(6): 423-427.
|
|
[14]
|
赵宇飞, 陈晓, 李薇. PD1/PD-L1抑制剂治疗肿瘤[J]. 中国肿瘤生物治疗杂志, 2017, 24(8): 904-911.
|
|
[15]
|
Koh, Y.W., Jeon, Y.K., Yoon, D.H., et al. (2016) Programmed Death 1expression in the Peritumoral Microenvironment Is Associated with a Poorer Prognosis in Classical Hodgkin Lymphoma. Tumor Biology, 37, 7507-7514. [Google Scholar] [CrossRef] [PubMed]
|